Congratulations to Małgorzata Firczuk, PhD DSc who was granted funding from the National Science Center in PRELUDIUM BIS 5 competition for the project entitled:
"Exploring kinase hyperactivation as an innovative approach for chemo-immunotherapy for B cell acute lymphoblastic leukemia”
The project will be conducted in the Laboratory of Immunology. It aims to develop new, targeted therapeutic strategies for the treatment of B-cell acute lymphoblastic leukemia based on chemo-immunotherapy. In the project, we are exploring a unique approach focused on enhancing the activity of kinase pathways in leukemia cells to induce their death and increase the expression of antigens vital for immunotherapy.
